Stock Analysis·← Pickers

AMIX

Autonomix Medical, Inc.

Autonomix Medical, Inc. (AMIX) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 30.8, with 0/3 trend checks passing.

Price
$5.13
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
30.8
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

AMIX with MA50 and MA200

31.2824.7418.2011.675.1307/3110/2401/2204/1707/15
AMIX2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$7.41-30.74% vs price
MA200
$12.03-57.37% vs price
RSI (14)
30.8Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for AMIX

Autonomix Medical, Inc. (AMIX) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $5.13, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 30.7% and below the 200-day moving average by 57.4%.

Momentum and stretch context

AMIX currently has an RSI reading of 30.8, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing AMIX next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Autonomix Medical, Inc.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Sector
Healthcare
Industry
Medical - Devices
CEO
Bradley A. Hauser
Employees
10
Market cap
$2.8M
Beta
-1.30
52-week range
$4.20 – $55.44
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
29 Jan 2024
ISIN
US05330T3041
CUSIP
05330T304
Company profile data from Financial Modeling Prep. AMIX listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about AMIX

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.